Predictive Factors of Clinical Response to Ustekinumab in Active Crohn’s Disease
Condition(s):Crohn DiseaseLast Updated:August 24, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Crohn DiseaseLast Updated:August 24, 2022Completed
Condition(s):Oral Squamous Cell Carcinoma; Neoadjuvant ChemotherapyLast Updated:December 9, 2019Completed
Condition(s):Crohn’s DiseaseLast Updated:January 29, 2018Terminated
Condition(s):Brain Injury; HyponatremiaLast Updated:September 8, 2016Terminated
Condition(s):Crohn’s DiseaseLast Updated:July 2, 2018Completed
Condition(s):Esophageal CancerLast Updated:August 12, 2019Unknown status
Condition(s):Breast Cancer; Breast Neoplasm; Breast Cancer Female; Breast Cancer Invasive; Breast Cancer Stage II; Breast Cancer Stage III; Triple Negative Breast Cancer; Hormone Receptor-positive Breast Cancer; HER2-positive Breast Cancer; Triple Negative Breast Neoplasms; Estrogen Receptor-positive Breast CancerLast Updated:January 16, 2024Recruiting
Condition(s):Inflammatory Bowel Diseases; Fecal Microbiota TransplantationLast Updated:March 4, 2020Completed
Condition(s):NSCLCLast Updated:March 5, 2018Unknown status
Condition(s):Breast Cancer; Chemotherapy EffectLast Updated:June 5, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.